| Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty. | |
| | |
MedLine Citation:
|
PMID: 8519045 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effect of probucol, a drug that inhibits the secretion of smooth muscle cell-derived growth factor, was evaluated in the prevention of restenosis after percutaneous transluminal coronary angioplasty (PTCA). In 67 patients who successfully underwent prospective PTCA for the first time, the effects obtained in 31 patients given 750 mg or 1000 mg of probucol daily (group P) were compared with those in 36 patients given 150 mg of dipyridamole daily (group D). Drug treatment was initiated at least 7 days before PTCA and was continued for 3 to 6 months after PTCA, at which time a follow-up angiography was performed. There were no significant differences in patient characteristics (age, sex, pre-PTCA severity of angina pectoris), the number of affected vessels undergoing dilatation, or the residual degree of stenosis. The restenosis rate was significantly lower in group P (6 cases, 19.4%) than in group D (15 cases, 41.7%). In the nonrestenosis subgroup, the degree of stenosis progressed from 28.0 +/- 13.9% just after PTCA to 32.4 +/- 20.5% at follow-up angiography in group P, while it progressed significantly from 28.6 +/- 15.6% to 40.1 +/- 21.2% in group D (P < 0.05). A significant drop in serum cholesterol was observed in group P. The restenosis rate was lower in patients with high cholesterol levels at PTCA. No adverse reactions were noted in any patient. We conclude that probucol is effective in preventing restenosis after PTCA. |
| | |
Authors:
|
M Setsuda; M Inden; N Hiraoka; S Okamoto; H Tanaka; T Okinaka; Y Nishimura; H Okano; T Kouji; T Konishi |
Related Documents
:
|
21861935 - Effects of hylan g-f 20 supplementation on cartilage preservation detected by magnetic ... 15050485 - Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta ... 21876095 - Effect of sonovue on the synovial membrane in rabbit knees. 19539255 - The paseo (paclitaxel or sirolimus-eluting stent versus bare metal stent in primary ang... 19625085 - The role of brucellacapt test for follow-up patients with brucellosis. 11916225 - The role of tamoxifen and aromatase inhibitors/inactivators in postmenopausal patients. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Clinical therapeutics Volume: 15 ISSN: 0149-2918 ISO Abbreviation: Clin Ther Publication Date: 1993 Mar-Apr |
Date Detail:
|
Created Date: 1993-07-26 Completed Date: 1993-07-26 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7706726 Medline TA: Clin Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 374-82 Citation Subset: IM |
Affiliation:
|
Matsusaka Central General Hospital, Mie, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angina Pectoris / surgery Angioplasty, Transluminal, Percutaneous Coronary* Cholesterol / blood Female Humans Male Middle Aged Myocardial Infarction / surgery Probucol / adverse effects, therapeutic use* Prospective Studies Recurrence |
| Chemical | |
Reg. No./Substance:
|
23288-49-5/Probucol; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapri...
Next Document: Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated o...